INTRAOSSEOUS INFUSION DEVICES MARKET ANALYSIS

Regional Analysis

Global Intraosseous Infusion Devices Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global intraosseous infusion devices market over the forecast period. North America is estimated to hold 33.5 % of the market share in 2023. The global intraosseous infusion devices market is expected to witness significant growth in the near future due to high prevalence of cardiovasular disorders, favorable health reimbursement, and increased awareness. Increasing prevalence of cancer is contributing to growth of the intraosseous infusion devices market in North America region. For instance, in 2022,  according to the National Center of Health Statistics, 1,918,030 new cancer cases and 609,360 cancer deathsare projected to occur in the U.S., which includes around 350 deaths per day from lung cancer, the leading cause of cancer deaths in 2023. This is expected to increase the number of chemotherapies in the U.S., thereby, boosting demand for intraosseous infusion devices in the U.S.